About Inspire Medical Systems, Inc.
https://www.inspiresleep.comInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
CEO
Timothy P. Herbert
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 189
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Truist Securities
Buy
Stifel
Buy
Lake Street
Buy
Mizuho
Outperform
RBC Capital
Outperform
Oppenheimer
Outperform
Grade Summary
Showing Top 6 of 17
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:3.55M
Value:$330.07M
VANGUARD GROUP INC
Shares:3M
Value:$279.16M
BLACKROCK INC.
Shares:1.86M
Value:$172.88M
Summary
Showing Top 3 of 388
About Inspire Medical Systems, Inc.
https://www.inspiresleep.comInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $224.5M ▲ | $183.08M ▼ | $9.93M ▲ | 4.42% ▲ | $0.34 ▲ | $17.24M ▲ |
| Q2-2025 | $217.09M ▲ | $185.73M ▲ | $-3.59M ▼ | -1.65% ▼ | $-0.12 ▼ | $1.09M ▼ |
| Q1-2025 | $201.32M ▼ | $172.09M ▲ | $2.99M ▼ | 1.49% ▼ | $0.1 ▼ | $1.56M ▼ |
| Q4-2024 | $239.72M ▲ | $171.85M ▲ | $35.22M ▲ | 14.69% ▲ | $1.18 ▲ | $56.75M ▲ |
| Q3-2024 | $203.19M | $156.47M | $18.5M | 9.1% | $0.62 | $22.18M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $322.59M ▲ | $807.72M ▲ | $141.26M ▲ | $666.46M ▼ |
| Q2-2025 | $300.89M ▼ | $802.19M ▲ | $124.38M ▲ | $677.81M ▲ |
| Q1-2025 | $369.19M ▼ | $730.81M ▼ | $95.07M ▼ | $635.74M ▼ |
| Q4-2024 | $445.55M ▲ | $808.38M ▲ | $118.69M ▲ | $689.7M ▼ |
| Q3-2024 | $410.99M | $796.19M | $99.63M | $696.56M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $9.93M ▲ | $68.53M ▲ | $-11.64M ▼ | $-51.08M ▼ | $5.92M ▼ | $58.09M ▲ |
| Q2-2025 | $-3.59M ▼ | $2.68M ▲ | $46.56M ▲ | $3.7M ▲ | $53.05M ▲ | $-6.31M ▲ |
| Q1-2025 | $2.99M ▼ | $-6.7M ▼ | $-1.55M ▼ | $-87.76M ▼ | $-96.27M ▼ | $-15.11M ▼ |
| Q4-2024 | $35.22M ▲ | $69.18M ▲ | $3.76M ▲ | $-70.14M ▼ | $2.64M ▲ | $62.15M ▲ |
| Q3-2024 | $18.5M | $52.28M | $-102.97M | $9.89M | $-40.52M | $44.28M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|
 Operating Segment | $200.00M ▲ | $220.00M ▲ | $220.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 NonUS | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 UNITED STATES | $230.00M ▲ | $190.00M ▼ | $210.00M ▲ | $210.00M ▲ |
CEO
Timothy P. Herbert
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 189
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Truist Securities
Buy
Stifel
Buy
Lake Street
Buy
Mizuho
Outperform
RBC Capital
Outperform
Oppenheimer
Outperform
Grade Summary
Showing Top 6 of 17
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:3.55M
Value:$330.07M
VANGUARD GROUP INC
Shares:3M
Value:$279.16M
BLACKROCK INC.
Shares:1.86M
Value:$172.88M
Summary
Showing Top 3 of 388